Silencing of ATPase inhibitory factor 1 inhibits cell growth via cell cycle arrest in bladder cancer

Pathobiology

Volumn 82, Issue 5, 2015, Pages 224-232

  Wei, Shihu ^a   Fukuhara, Hideo ^a   Kawada, Chiaki ^a   Kurabayashi, Atsushi ^a   Furihata, Mutsuo ^a   Ogura, Shun Ichiro ^b   Inoue, Keiji ^a   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

ATPase inhibitory factor 1; Bladder cancer; Cell cycle arrest; Knockdown; Proliferation

Indexed keywords

ATPASE INHIBITORY FACTOR 1; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; ATPASE INHIBITORY PROTEIN; CDK2 PROTEIN, HUMAN; CDK6 PROTEIN, HUMAN; CYCLINE; PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BLADDER CANCER; BLADDER TISSUE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; EPITHELIUM CELL; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MIGRATION INHIBITION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ADULT; AGED; BLADDER TUMOR; CELL CYCLE; CELL CYCLE CHECKPOINT; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEINS; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 84942258003     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000439027     Document Type: Article

References (25)

1. Garcia JJ, Morales-Rios E, Cortes-Hernandez P, Rodriguez-Zavala JS: The inhibitor protein (IF1) promotes dimerization of the mitochondrial F 1 F o-ATP synthase. Biochemistry 2006; 45: 12695-12703.
2. Campanella M, Parker N, Tan CH, Hall AM, Duchen MR: IF(1): setting the pace of the F(1) F(o)-ATP synthase. Trends Biochem Sci 2009; 34: 343-350.
3. Shah DI, Takahashi-Makise N, Cooney JD, et al: Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature 2012; 491: 608-612.
4. Campanella M, Seraphim A, Abeti R, Casswell E, Echave P, Duchen MR: IF1, the endogenous regulator of the F(1)F(o)-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagy. Biochim Biophys Acta 2009; 1787: 393-401.
5. Lefebvre V, Du Q, Baird S, et al: Genomewide RNAi screen identifies ATPase inhibitory factor 1 (ATPIF1) as essential for PARK2 recruitment and mitophagy. Autophagy 2013; 9: 1770-1779.
6. Formentini L, Sanchez-Arago M, Sanchez-Cenizo L, Cuezva JM: The mitochondrial ATPase inhibitory factor 1 triggers a ROSmediated retrograde prosurvival and proliferative response. Mol Cell 2012; 45: 731-742.
7. Song R, Song H, Liang Y, et al: Reciprocal activation between ATPase inhibitory factor 1 and NF-?B drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology 2014; 60: 1659-1673.
8. Sanchez-Arago M, Garcia-Bermudez J, Martinez-Reyes I, Santacatterina F, Cuezva JM: Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells. EMBO Rep 2013; 14: 638-644.
9. Sanchez-Cenizo L, Formentini L, Aldea M, et al: Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem 2010; 285: 25308-25313.
10. Sanchez-Arago M, Formentini L, Martinez-Reyes I, et al: Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis 2013; 2:e46.
11. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
12. Giacoia EG, Miyake M, Lawton A, Goodison S, Rosser CJ: PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation. Mol Cancer Res 2014; 12: 322-334.
13. Faccenda D, Tan CH, Seraphim A, Duchen MR, Campanella M: IF1 limits the apoptoticsignalling cascade by preventing mitochondrial remodelling. Cell Death Differ 2013; 20: 686-697.
14. Wei S, Fukuhara H, Chen G, et al: Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo. Pathobiology 2014; 81: 123-132.
15. Polireddy K, Chavan H, Abdulkarim BA, Krishnamurthy P: Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma. Mol Oncol 2011; 5: 410-425.
16. Dai Y, Wilson G, Huang B, et al: Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death Dis 2014; 5: e1170.
17. Sohn YS, Tamir S, Song L, et al: NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth. Proc Natl Acad Sci U S A 2013; 110: 14676-14681.
18. Chen WW, Birsoy K, Mihaylova MM, et al: Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep 2014; 7: 27-34.
19. Bravo C, Minauro-Sanmiguel F, Morales-Rios E, Rodriguez-Zavala JS, Garcia JJ: Overexpression of the inhibitor protein IF 1 in AS-30D hepatoma produces a higher association with mitochondrial F 1 F o ATP synthase compared to normal rat liver: functional and cross-linking studies. J Bioenerg Biomembr 2004; 36: 257-264.
20. Chernyak BV, Dedov VN, Gabai VL: Mitochondrial ATP hydrolysis and ATP depletion in thymocytes and Ehrlich ascites carcinoma cells. FEBS Lett 1997; 337: 56-59.
21. Kang YJ, Chung HJ, Nam JW, et al: Cytotoxic and antineoplastic activity of timosaponin AIII for human colon cancer cells. J Nat Prod 2011; 74: 701-706.
22. Cmielova J, Rezacova M: p21 Cip1/Waf1 protein and its function based on a subcellular localization. J Cell Biochem 2011; 112: 3502-3506.
23. Hu XT, Zuckerman KS: Role of cell cycle regulatory molecules in retinoic acid-and vitamin D3-induced differentiation of acute myeloid leukaemia cells. Cell Prolif 2014; 47: 200-210.
24. Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-414.
25. Fujikawa M, Imamura H, Nakamura J, Yoshida M: Assessing actual contribution of IF1, inhibitor of mitochondrial F o F 1 , to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability. J Biol Chem 2012; 287: 18781-18787.